BELGIUM, Wis.--(BUSINESS WIRE)--Mach One Corporation (OTCBB:MNCN), a rapidly growing, innovative, global wellness solutions company, announced today that it has entered into a multi-year, sole-source agreement with PanTheryx, Inc. to supply proprietary bio-based ingredients for the manufacture of a broad-spectrum pediatric diarrhea product. Through a wholly owned subsidiary in India, PanTheryx produces and sells “branded generic” pharmaceuticals and proprietary US-originated products and technologies specifically designed for the emerging Indian healthcare market.
